Diadema Partners »

Cogent Biosciences shares owned by Diadema Partners

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.3M 298k 14.36

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Cogent Biosciences

FMR
BlackRock
Deerfield Management Company
Fairmount Funds Management
Kynam Capital Management
Vanguard Group
Commodore Capital
TCG Crossover Management
State Street Corporation
VR Adviser
Rtw Investments
Geode Capital Management
Henderson Group
Paradigm Biocapital Advisors
Octagon Capital Advisors

View all funds holding Cogent Biosciences